Literature DB >> 16553024

Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders.

Clete A Kushida1, Michael R Littner, Max Hirshkowitz, Timothy I Morgenthaler, Cathy A Alessi, Dennis Bailey, Brian Boehlecke, Terry M Brown, Jack Coleman, Leah Friedman, Sheldon Kapen, Vishesh K Kapur, Milton Kramer, Teofilo Lee-Chiong, Judith Owens, Jeffrey P Pancer, Todd J Swick, Merrill S Wise.   

Abstract

Positive airway pressure (PAP) devices are used to treat patients with sleep related breathing disorders (SRBD) including obstructive sleep apnea (OSA). Currently, PAP devices come in three forms: (1) continuous positive airway pressure (CPAP), (2) bilevel positive airway pressure (BPAP), and (3) automatic self-adjusting positive airway pressure (APAP). After a patient is diagnosed with OSA, the current standard of practice involves performing full, attended polysomnography during which positive pressure is adjusted to determine optimal pressure for maintaining airway patency. This titration is used to find a fixed single pressure for subsequent nightly usage. A task force of the Standards of Practice Committee of the American Academy of Sleep Medicine reviewed the available literature. Based on this review, the Standards of Practice Committee developed these practice parameters as a guideline for using CPAP and BPAP appropriately (an earlier review and practice parameters for APAP was published in 2002). Major conclusions and current recommendations are as follows: 1) A diagnosis of OSA must be established by an acceptable method. 2) CPAP is effective for treating OSA. 3) Full-night, attended studies performed in the laboratory are the preferred approach for titration to determine optimal pressure; however, split-night, diagnostic-titration studies are usually adequate. 4) CPAP usage should be monitored objectively to help assure utilization. 5) Initial CPAP follow-up is recommended during the first few weeks to establish utilization pattern and provide remediation if needed. 6) Longer-term follow-up is recommended yearly or as needed to address mask, machine, or usage problems. 7) Heated humidification and a systematic educational program are recommended to improve CPAP utilization. 8) Some functional outcomes such as subjective sleepiness improve with positive pressure treatment in patients with OSA. 9) CPAP and BPAP therapy are safe; side effects and adverse events are mainly minor and reversible. 10) BPAP may be useful in treating some forms of restrictive lung disease or hypoventilation syndromes associated with hypercapnia.

Entities:  

Mesh:

Year:  2006        PMID: 16553024     DOI: 10.1093/sleep/29.3.375

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  214 in total

1.  Driving on "auto": hands-on is more effective than hands-free.

Authors:  Barry Krakow; Victor A Ulibarri; Jessica N Sanchez; Shara Kikta; Natalia McIver; Dominic Melendrez
Journal:  J Clin Sleep Med       Date:  2012-06-15       Impact factor: 4.062

2.  Treatment of CSA: a letter to the editor by N.S. Freedman and B.A. Phillips and responses by S. Chowdhuri, et al., on the Task Force report on the Treatment of Adult CSA.

Authors:  Neil S Freedman; Barbara A Phillips
Journal:  Sleep       Date:  2012-07-01       Impact factor: 5.849

Review 3.  Continuous positive airway pressure reduces risk of motor vehicle crash among drivers with obstructive sleep apnea: systematic review and meta-analysis.

Authors:  Stephen Tregear; James Reston; Karen Schoelles; Barbara Phillips
Journal:  Sleep       Date:  2010-10       Impact factor: 5.849

4.  Predictive equations for CPAP titration in OSAS patients.

Authors:  Donato Lacedonia; Roberto Sabato; Giovanna E Carpagnano; Pierluigi Carratù; Antonio Falcone; Felice Gadaleta; Onofrio Resta; Maria P Foschino Barbaro
Journal:  Sleep Breath       Date:  2011-01-06       Impact factor: 2.816

5.  Diagnostic accuracy of split-night polysomnograms.

Authors:  Imran S Khawaja; Eric J Olson; Christelle van der Walt; Jan Bukartyk; Virend Somers; Ross Dierkhising; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2010-08-15       Impact factor: 4.062

6.  Use of complementary and alternative medicine treatments by patients with obstructive sleep apnea hypopnea syndrome.

Authors:  Amit Sood; Sujata Narayanan; Dietlind L Wahner-Roedler; Kayla Knudsen; Richa Sood; Laura L Loehrer; Andrew C Hanson; Tomasz J Kuzniar; Eric J Olson
Journal:  J Clin Sleep Med       Date:  2007-10-15       Impact factor: 4.062

7.  DRIVING PERFORMANCE AND DRIVER STATE IN OBSTRUCTIVE SLEEP APNEA: WHAT CHANGES WITH POSITIVE AIRWAY PRESSURE?

Authors:  Nazan Aksan; Robert Marini; Jon Tippin; Jeffrey Dawson; Matthew Rizzo
Journal:  Proc Int Driv Symp Hum Factors Driv Assess Train Veh Des       Date:  2017

8.  Prevalence and Sources of Errors in Positive Airway Pressure Therapy Provisioning.

Authors:  Cinthya Pena Orbea; Kara L Dupuy-McCauley; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2019-05-15       Impact factor: 4.062

9.  Fractalkine in obstructive sleep apnea patients.

Authors:  Gulgun Cetintas Afsar; Ozlem Oruc; Sema Sarac; Özgür Bilgin Topçuoğlu; Cuneyt Salturk; Fatma Merve Tepetam; Ismet Bulut
Journal:  Sleep Breath       Date:  2016-10-17       Impact factor: 2.816

Review 10.  Obstructive sleep apnea, hypertension and cardiovascular diseases.

Authors:  C Gonzaga; A Bertolami; M Bertolami; C Amodeo; D Calhoun
Journal:  J Hum Hypertens       Date:  2015-03-12       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.